HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Craig C Malbon Selected Research

Teratocarcinoma

12/2009Dishevelled-2 docks and activates Src in a Wnt-dependent manner.
11/2008p38 mitogen-activated protein kinase regulates canonical Wnt-beta-catenin signaling by inactivation of GSK3beta.
9/2008Wnt and Frizzled RNA expression in human mesenchymal and embryonic (H7) stem cells.
5/2008OSTM1 regulates beta-catenin/Lef1 interaction and is required for Wnt/beta-catenin signaling.
10/2007Phosphoprotein phosphatase-2A docks to Dishevelled and counterregulates Wnt3a/beta-catenin signaling.
10/2007Abundance, complexation, and trafficking of Wnt/beta-catenin signaling elements in response to Wnt3a.
10/2007RGS19 regulates Wnt-beta-catenin signaling through inactivation of Galpha(o).
1/2004Gene profiling of Frizzled-1 and Frizzled-2 signaling: expression of G-protein-coupled receptor chimeras in mouse F9 teratocarcinoma embryonal cells.
8/2002Activation of the beta-catenin/Lef-Tcf pathway is obligate for formation of primitive endoderm by mouse F9 totipotent teratocarcinoma cells in response to retinoic acid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Craig C Malbon Research Topics

Disease

9Teratocarcinoma
12/2009 - 08/2002
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2010 - 11/2002
1Familial Exudative Vitreoretinopathies
11/2015
1Carcinogenesis
11/2008
1Atherosclerosis
06/2008
1Osteopetrosis
05/2008
1Neoplasms (Cancer)
07/2005
1Breast Neoplasms (Breast Cancer)
03/2003

Drug/Important Bio-Agent (IBA)

8beta CateninIBA
12/2009 - 08/2002
2Insulin (Novolin)FDA Link
02/2004 - 11/2002
1Retinaldehyde (Retinal)IBA
11/2015
1Adrenergic Agents (Adrenergic Drugs)IBA
04/2010
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2009
1Mitogen-Activated Protein KinasesIBA
11/2008
1p38 Mitogen-Activated Protein KinasesIBA
11/2008
1LigandsIBA
09/2008
1RNA (Ribonucleic Acid)IBA
09/2008
1Messenger RNA (mRNA)IBA
06/2008
1Proteins (Proteins, Gene)FDA Link
06/2008
1Apolipoproteins E (ApoE)IBA
06/2008
1ApolipoproteinsIBA
06/2008
1Glycogen Synthase (Synthase I)IBA
10/2007
1Glycogen Synthase KinasesIBA
10/2007
1RGS ProteinsIBA
10/2007
1GTP-Binding Proteins (G-Protein)IBA
07/2005
1LipidsIBA
07/2005
1NocodazoleIBA
02/2004
1TubulinIBA
02/2004
1Adrenergic beta-Agonists (beta-Adrenergic Agonists)IBA
02/2004
1FollistatinIBA
01/2004
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2004
1Protein Kinases (Protein Kinase)IBA
03/2003
1Phosphotransferases (Kinase)IBA
03/2003
1Mitogen-Activated Protein Kinase PhosphatasesIBA
03/2003
1Tretinoin (Retinoic Acid)FDA LinkGeneric
08/2002